default author photo

Fuyan Shi

Baogang Hospital of Inner Mongolia

Baotou

China

SCHOLARLY PAPERS

2

DOWNLOADS

175

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Efficacy and Safety of the Peroxisome Proliferator-Activated Receptor Pan-Agonist Chiglitazar in Patients with Type 2 Diabetes (CMAP): A 24 Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase 3 Superiority Trial

Number of pages: 100 Posted: 21 Aug 2019
Peking University - Department of Endocrinology and Metabolism, Southern Medical University - Chenzhou No.1 People's Hospital, Tangshan Gongren Hospital, Xuzhou Medical University, Harrison International Peace Hospital, Qingdao University - Affiliated Hospital, China Three Gorges University (CTGU) - College of Medical Science, Jilin University (JLU) - Second Hospital, Jiangsu Province Hospital, China Meitan General Hospital, Chongqing University, Chongqing Medical University - Department of Endocrinology, Hebei Medical University, Tianjin Medical University - General Hospital, Government of the People's Republic of China - 306th Hospital, Baogang Hospital of Inner Mongolia, Cangzhou Central Hospital, Fudan University - Zhongshan Hospital, Sichuan University, Government of the People's Republic of China - Air Force Medical University, Shanghai Jiao Tong University (SJTU) - Xinhua Hospital, Central South University - Key Laboratory of Diabetes Immunology, Peking University, Central South University - Second Xiangya Hospital, Xiamen University - First Affiliated Hospital, Wuhan University - Zhongnan Hospital, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd and Shanghai Jiao Tong University (SJTU) - Department of Endocrinology and Metabolism
Downloads 94 (720,278)

Abstract:

Loading...

2.

Immunological and Clinical Immunotherapy Implications of NLRP3 Mutations in Melanoma

Number of pages: 23 Posted: 15 Oct 2020
Department of Health Statistics, School of Public Health, Weifang Medical University, Department of Health Statistics, School of Public Health, Weifang Medical University, Baogang Hospital of Inner Mongolia, Department of Health Statistics, School of Public Health, Weifang Medical University, Department of Health Statistics, School of Public Health, Weifang Medical University, Department of Health Statistics, School of Public Health, Weifang Medical University, Department of Bone and Soft Tissue Tumor, Tianjin Medical University, Tianjin Medical University - National Clinical Research Center for Cancer and Weifang Medical University - Department of Health Statistics
Downloads 81 (796,622)

Abstract:

Loading...

Melanoma, Immunotherapy, NLRP3 mutations, predictive indicator